Clinical
Frederick S. Nolte, Ph.D., D(ABMM), F(AAM), shares his insight regarding the recent FDA reclassification of Rapid Antigen flu testing, and why it's an opportunity for lab leadership.
Frederick S. Nolte, PhD, D(ABMM), F(AAM)
Director of Clinical Laboratories
Medical University of South Carolina